In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proposed Tariffs Threaten Ingredient Supply Chain For US Supplement Firms

This article is powered by The Rose Sheet

Executive Summary

NPA sounds alarm on Trump administration tariffs on $200bn in Chinese goods scheduled for October. In letter US Trade Representative, NPA President and CEO Daniel Fabricant asks the agency to exempt 57 items from the Harmonized Tariff Schedule that would impact hundreds of dietary ingredients.

Advertisement

Related Content

Trump's Chinese Import Tariff Hike Could Take Toll On Consumer Health Sector
Trump's Chinese Import Tariff Hike Could Take Toll On Consumer Health Sector
Higher Consumer Health Price Tags Ahead As Chinese Import Tariff Increases
FDA Warning, Not Tariffs, Stop Canadian Supplement Firm 'Drug' Exports To US
NPA Submits Wish List For Reducing FDA Regulatory Burdens Per Trump Order

Topics

Advertisement
UsernamePublicRestriction

Register

RS121758

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel